$INSP
Inspire Medical Systems, Inc.

2020 Q2 Form 10-Q Financial Statement

#000160955020000036 Filed on August 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $12.18M $18.03M
YoY Change -32.44% 64.86%
Cost Of Revenue $1.954M $3.094M
YoY Change -36.85% 47.19%
Gross Profit $10.23M $14.94M
YoY Change -31.52% 69.06%
Gross Profit Margin 83.96% 82.84%
Selling, General & Admin $26.98M $20.27M
YoY Change 33.1% 59.11%
% of Gross Profit 263.76% 135.69%
Research & Development $6.062M $2.846M
YoY Change 113.0% 64.03%
% of Gross Profit 59.26% 19.05%
Depreciation & Amortization $190.0K $110.0K
YoY Change 72.73% 10.0%
% of Gross Profit 1.86% 0.74%
Operating Expenses $33.04M $23.11M
YoY Change 42.96% 59.7%
Operating Profit -$22.81M -$8.176M
YoY Change 179.04% 45.04%
Interest Expense $526.0K $523.0K
YoY Change 0.57% -4.91%
% of Operating Profit
Other Income/Expense, Net -$275.0K $526.0K
YoY Change -152.28% -340.18%
Pretax Income -$23.09M -$7.650M
YoY Change 201.82% 30.64%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$23.09M -$7.650M
YoY Change 201.82% 30.64%
Net Earnings / Revenue -189.52% -42.42%
Basic Earnings Per Share -$0.88
Diluted Earnings Per Share -$0.88 -$322.1K
COMMON SHARES
Basic Shares Outstanding 26.29M shares 23.81M shares
Diluted Shares Outstanding 26.29M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $242.6M $158.6M
YoY Change 52.96% 27.9%
Cash & Equivalents $211.2M $51.27M
Short-Term Investments $31.30M $107.4M
Other Short-Term Assets $4.300M $5.600M
YoY Change -23.21% 460.0%
Inventory $9.966M $3.561M
Prepaid Expenses $4.348M $5.596M
Receivables $10.24M $9.465M
Other Receivables $0.00 $0.00
Total Short-Term Assets $267.1M $177.2M
YoY Change 50.7% 33.26%
LONG-TERM ASSETS
Property, Plant & Equipment $3.307M $1.826M
YoY Change 81.11% 102.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $6.100M
YoY Change -100.0%
Other Assets $500.0K $400.0K
YoY Change 25.0%
Total Long-Term Assets $4.200M $8.323M
YoY Change -49.54% 824.78%
TOTAL ASSETS
Total Short-Term Assets $267.1M $177.2M
Total Long-Term Assets $4.200M $8.323M
Total Assets $271.3M $185.6M
YoY Change 46.21% 38.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.100M $2.700M
YoY Change 88.89% 22.73%
Accrued Expenses $7.939M $5.980M
YoY Change 32.76% 35.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.04M $8.661M
YoY Change 50.58% -6.87%
LONG-TERM LIABILITIES
Long-Term Debt $24.60M $24.40M
YoY Change 0.82% 10.91%
Other Long-Term Liabilities $40.00K
YoY Change
Total Long-Term Liabilities $40.00K $24.40M
YoY Change -99.84% 10.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.04M $8.661M
Total Long-Term Liabilities $40.00K $24.40M
Total Liabilities $37.71M $33.08M
YoY Change 14.02% 5.67%
SHAREHOLDERS EQUITY
Retained Earnings -$219.5M -$162.8M
YoY Change 34.79%
Common Stock $27.00K $24.00K
YoY Change 12.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $233.6M $152.5M
YoY Change
Total Liabilities & Shareholders Equity $271.3M $185.6M
YoY Change 46.21% 38.58%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$23.09M -$7.650M
YoY Change 201.82% 30.64%
Depreciation, Depletion And Amortization $190.0K $110.0K
YoY Change 72.73% 10.0%
Cash From Operating Activities -$25.25M -$12.89M
YoY Change 95.89% 110.28%
INVESTING ACTIVITIES
Capital Expenditures -$380.0K -$950.0K
YoY Change -60.0% 1800.0%
Acquisitions
YoY Change
Other Investing Activities $34.30M -$38.06M
YoY Change -190.12% -918.49%
Cash From Investing Activities $33.92M -$39.03M
YoY Change -186.91% -950.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 126.4M 1.250M
YoY Change 10015.2% -98.89%
NET CHANGE
Cash From Operating Activities -25.25M -12.89M
Cash From Investing Activities 33.92M -39.03M
Cash From Financing Activities 126.4M 1.250M
Net Change In Cash 135.1M -50.67M
YoY Change -366.65% -145.77%
FREE CASH FLOW
Cash From Operating Activities -$25.25M -$12.89M
Capital Expenditures -$380.0K -$950.0K
Free Cash Flow -$24.87M -$11.94M
YoY Change 108.29% 96.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001609550
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201613Member
CY2020Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseRightOfUseAsset
CY2020Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38468
dei Entity Registrant Name
EntityRegistrantName
Inspire Medical Systems, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1377674
dei Entity Address Address Line1
EntityAddressAddressLine1
5500 Wayzata Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1600
dei Entity Address City Or Town
EntityAddressCityOrTown
Golden Valley
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55416
dei City Area Code
CityAreaCode
844
dei Local Phone Number
LocalPhoneNumber
672-4357
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
INSP
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26800071 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
211237000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22860000 USD
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
31322000 USD
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
126605000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
48000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10235000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13131000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
9966000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
5834000 USD
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4348000 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2206000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
267108000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
170636000 USD
CY2020Q2 us-gaap Long Term Investments
LongTermInvestments
0 USD
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
6276000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3307000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3045000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
424000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
915000 USD
CY2020Q2 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
469000 USD
CY2019Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
381000 USD
CY2020Q2 us-gaap Assets
Assets
271308000 USD
CY2019Q4 us-gaap Assets
Assets
181253000 USD
CY2020Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
5103000 USD
CY2019Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4459000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7939000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12397000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13042000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16856000 USD
CY2020Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
24632000 USD
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
24522000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
40000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
40000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
37714000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
41418000 USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26751091 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26751091 shares
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39838000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
27000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
24000 USD
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24107350 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24107350 shares
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
452891000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
319865000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
154000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
102000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-219478000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-180156000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
233594000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
139835000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
271308000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
181253000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12183000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18032000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33530000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34282000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1954000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3094000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5251000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5948000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
10229000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
14938000 USD
us-gaap Gross Profit
GrossProfit
28279000 USD
us-gaap Gross Profit
GrossProfit
28334000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6062000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2846000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11500000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5449000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26981000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20268000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
56033000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
33043000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
23114000 USD
us-gaap Operating Expenses
OperatingExpenses
67533000 USD
us-gaap Operating Expenses
OperatingExpenses
45287000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-22814000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8176000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-39254000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16953000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
248000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1036000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
890000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2122000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
526000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
523000 USD
us-gaap Interest Expense
InterestExpense
1051000 USD
us-gaap Interest Expense
InterestExpense
1060000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
81000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-275000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
526000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-80000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1037000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23089000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7650000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39334000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15916000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-23089000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-7650000 USD
us-gaap Profit Loss
ProfitLoss
-39334000 USD
us-gaap Profit Loss
ProfitLoss
-15916000 USD
CY2020Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-141000 USD
CY2019Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
35000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
52000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
103000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23230000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7615000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39282000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15813000 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.88
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.56
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26289272 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23753647 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25227574 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23598466 shares
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
139835000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
787000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
72000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2749000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
193000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-16245000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
127403000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
732000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
73000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1059000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2903000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-141000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-23089000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
233594000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
163999000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
166000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
58000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1391000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
68000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-8266000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
157416000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
604000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
58000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
637000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1389000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
35000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-7650000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
152489000 USD
us-gaap Profit Loss
ProfitLoss
-39334000 USD
us-gaap Profit Loss
ProfitLoss
-15916000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
375000 USD
insp Sharebased Compensation Noncash Services
SharebasedCompensationNoncashServices
145000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
209000 USD
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
88000 USD
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
609000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
110000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
161000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
491000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
433000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
5652000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2780000 USD
insp Sharebased Compensation Noncash Services
SharebasedCompensationNoncashServices
116000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
98000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
141000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-2905000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2801000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4131000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
894000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2233000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4284000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
639000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-745000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4459000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2135000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40026000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23826000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
636000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1233000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
14907000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
101037000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
116703000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
79204000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
101160000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23066000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
531000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1519000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
769000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
124654000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
insp Proceeds From Issuance Of Common Stock From Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockFromEmployeeStockPurchasePlan
1059000 USD
insp Proceeds From Issuance Of Common Stock From Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockFromEmployeeStockPurchasePlan
637000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
127232000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
875000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
188377000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46020000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22860000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97288000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
211237000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51268000 USD
us-gaap Interest Paid Net
InterestPaidNet
947000 USD
us-gaap Interest Paid Net
InterestPaidNet
1087000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the financial statements. We use significant judgment when making estimates related to the allowance for credit losses, inventory reserves, warranty reserves, and the valuation of stock-based awards. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div>
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
200000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
100000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 USD
CY2019Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
100000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 USD
CY2020Q2 insp Investments Allowance For Credit Loss
InvestmentsAllowanceForCreditLoss
0 USD
CY2019Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0 USD
CY2019Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0 USD
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2020Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0 USD
CY2019Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0 USD
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Concentration of Credit Risk</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash equivalents, investments, and accounts receivable. </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our investment policy limits investments to certain types of debt securities issued by the U.S. government and its agencies, corporations with investment-grade credit ratings, or commercial paper and money market funds issued by the highest quality financial and non-financial companies. We place restrictions on maturities and concentration by type and issuer. We are exposed to credit risk in the event of a default by the issuers of these securities to the extent recorded on the balance sheets. However, as of June 30, 2020 and December 31, 2019, we limited our credit risk associated with cash equivalents by placing investments with banks we believe are highly creditworthy.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that the credit risk in our accounts receivable is mitigated by our credit evaluation process, relatively short collection terms, and dispersion of our customer base. We generally do not require collateral, and losses on accounts receivable have historically been within management's expectations.</span></div>
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1005000 USD
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1070000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
781000 USD
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8896000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5053000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
9966000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
5834000 USD
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4687000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1380000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4050000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3307000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3045000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000 USD
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
400000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000 USD
CY2020Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
6968000 USD
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
10304000 USD
CY2020Q2 us-gaap Interest Payable Current
InterestPayableCurrent
155000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
160000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
338000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
828000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
478000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1105000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7939000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12397000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q2 us-gaap Advertising Expense
AdvertisingExpense
5000000.0 USD
CY2019Q2 us-gaap Advertising Expense
AdvertisingExpense
4400000 USD
us-gaap Advertising Expense
AdvertisingExpense
11400000 USD
us-gaap Advertising Expense
AdvertisingExpense
7900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1800000 USD
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1800000 USD
CY2020Q2 insp Operating Leases Future Minimum Payments Net Present Value
OperatingLeasesFutureMinimumPaymentsNetPresentValue
7400000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
424000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
915000 USD
CY2020Q2 insp Operating Lease Liability Gross
OperatingLeaseLiabilityGross
338000 USD
CY2019Q4 insp Operating Lease Liability Gross
OperatingLeaseLiabilityGross
828000 USD
insp Operating Lease Remaining Lease Term
OperatingLeaseRemainingLeaseTerm
P0Y4M24D
CY2020Q2 insp Operating Lease Remaining Lease Discount Rate Percent
OperatingLeaseRemainingLeaseDiscountRatePercent
0.080
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
200000 USD
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
300000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
500000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
500000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9188000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
24500000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
12250000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3062000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2844164 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.41
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
124585000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
172331 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
77.12
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
324995 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.67
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
18795000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
42279 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
36.03
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2649221 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
36.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
133806000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1132084 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
13.79
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
insp Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable
82906000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2903000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1389000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5652000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2780000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
33900000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34282000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
100000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
100000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12183000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18032000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33530000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2649221 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2371654 shares

Files In Submission

Name View Source Status
0001609550-20-000036-index-headers.html Edgar Link pending
0001609550-20-000036-index.html Edgar Link pending
0001609550-20-000036.txt Edgar Link pending
0001609550-20-000036-xbrl.zip Edgar Link pending
a2020-q2ex31x1.htm Edgar Link pending
a2020-q2ex31x2.htm Edgar Link pending
a2020-q2ex32x1.htm Edgar Link pending
a2020-q2ex32x2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
insp-20200630.htm Edgar Link pending
insp-20200630.xsd Edgar Link pending
insp-20200630_cal.xml Edgar Link unprocessable
insp-20200630_def.xml Edgar Link unprocessable
insp-20200630_g1.jpg Edgar Link pending
insp-20200630_htm.xml Edgar Link completed
insp-20200630_lab.xml Edgar Link unprocessable
insp-20200630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending